MedPath

Is 5-alpha reductase inhibitor capable to alter the natural history of slightly enlarged prostate? a prospective multi center study

Phase 1
Conditions
Benign Prostatic Hyperplasia
Registration Number
JPRN-UMIN000027832
Lead Sponsor
Sapporo medical university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
Male
Target Recruitment
27
Inclusion Criteria

Not provided

Exclusion Criteria

use of drugs affecting prostate volume such as antiandrogenic agent

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
change of prostate volume and adherence to prescribed drugs
Secondary Outcome Measures
NameTimeMethod
change of LUTS
© Copyright 2025. All Rights Reserved by MedPath